The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

For decades, the pharmaceutical industry has defended sky-high drug prices by pointing to the high costs of research and development. But the real story reveals something else entirely. A closer look ...

Sanofi has replaced its CEO Paul Hudson after a series of R&D setbacks at the French pharma, handing the reins to Merck KGaA leader Belén Garijo, M.D., Ph.D. Following the departure of GSK CEO Emma ...

SAN FRANCISCO, Feb 11 (Reuters) - Some pharmaceutical companies not targeted by President Donald Trump for agreements to lower their U.S. drug pricing are looking to craft their own deals in an ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. As President Trump hails ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet. How did Pfizer slash billions in spending ...

Generic drugs produced in non-advanced economies exhibit substantially higher serious recall rates, reflecting reverse-engineering limitations and market incentives that underfund quality ...

If last year’s pharma ad showing during the Super Bowl drove buzzy conversation and a touch of controversy, the lasting impression pharma marketers made on consumers during Sunday’s Super Bowl LX took ...

Feb 9 (Reuters) - Indian drugmaker Aurobindo Pharma (ARBN.NS), opens new tab reported a 7.6% rise in profit on Monday, helped by steady domestic demand, especially for its anti-retroviral drugs for ...

Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant ...